How Ripk3 Affects Lung Injury and Cell Death
Author Information
Author(s): Zhao Zhaoning, Zhu Pingjun, Lou Yue, Hou Ruoyu, Sun Heqiang, Du Yingzhen, Xu Guogang
Primary Institution: Health Management Institute, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Hypothesis
Ripk3 influences mitochondrial fission, leading to the initiation of necroptosis in the development of ARDS.
Conclusion
Ripk3 deletion protects against LPS-induced acute lung injury by alleviating inflammation, oxidative stress, and tissue damage.
Supporting Evidence
- Ripk3 is upregulated in lung tissues after LPS treatment.
- Ripk3 deletion improves lung tissue morphology and reduces inflammation.
- Ripk3 promotes necroptosis through the AMPK/Drp1/mPTP opening pathway.
Takeaway
This study shows that a protein called Ripk3 can cause lung cells to die in a harmful way when the lungs are injured, but removing Ripk3 can help protect the lungs.
Methodology
The study used Ripk3-deficient mice and various assays to assess lung injury, inflammation, and mitochondrial function.
Limitations
The in vitro environment may not fully replicate the complex in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website